RE:52w low - $2.60!If more dilution is coming (as some think it is based on Colwill's comments from last week), everyone has to think about what this will do to the sp which in turn could quite possibly affect Inmed's ability to remain on the Nasdaq.
The sp is already at new 52 week lows and a cap raise at this level would destroy the sp. There are minimum requirements to stay on the Nasdaq - if you aren't familiar with what they are, i'd suggest Googling it.
I guess they'd have to do another reverse split to keep the sp above the $4.00 required level.
Adams has really put this company in a very precarious situation.
Actually, he has really put his shareholders in a very precarious situation.
I've never really seen such blatant ineptitude (and I was invested in Enron....)